logo
Harvard Found a Way to Make Rubber 10x Tougher and It Could Be Big for Cars

Harvard Found a Way to Make Rubber 10x Tougher and It Could Be Big for Cars

The Drive2 days ago
The latest car news, reviews, and features.
Natural rubber is a wonder material. Few discoveries or innovations come close to its impact on manufacturing, and the car industry is just one of many that depend on it for critical components, such as gaskets, seals, and tires. There's just one problem: It cracks, and once that happens, it's not good for much. That's why researchers at the Harvard School of Engineering and Applied Sciences started tooling around with natural rubber here recently to see if they could make it more durable. And what do you know, they were able to make it 10 times tougher than before with a tweak to the vulcanization process.
See, the science involved in vulcanized rubber production hasn't changed much since Charles Goodyear patented it in 1844. You start with natural rubber latex that comes from Hevea trees, and once it's harvested, it's coagulated, dried, mixed with additives, shaped, and heated. The high-intensity process forms short polymer chains within the material, as the Harvard SEAS writes, resulting in chemical bonds.
The Harvard scientists had an idea: 'What if we're gentler with it?' Sounds crazy, I know, but that one tweak brought about a result that surprised even their bright minds. It was instantly four times better at resisting slow crack growth, even after repeated stretching.
'We imagined that the properties would be enhanced maybe twice or three times, but actually they were enhanced by one order of magnitude,' said Zheqi Chen, a former SEAS postdoctoral researcher and first co-author of the paper. Harvard School of Engineering and Applied Science
The change in process, which was based on latex processing methods, preserved the long polymer chains rather than forming shorter ones. Long 'tanglemers' inside the material resemble spaghetti noodles rather than a tightly-bound grid. Stress is then able to be spread out across those tanglemers, greatly improving its resistance to cracking and snapping.
Not only is it more resistant to cracks, but it becomes tougher under the conditions that would normally cause natural rubber to fail. It wouldn't be accurate to call the material 'self-healing,' but as the new rubber stretches and small cracks form, those spaghetti tanglemers allow more crystallization. That means the overall strength increases under those circumstances.
This video demonstrates it well:
This process isn't especially well-suited to automotive applications like tires, at least in its current form. Water evaporation is high, yielding a smaller volume of material than companies would want to wrap around a car's wheels. The Harvard SEAS writes that, for now, it's better suited for gloves and other thin applications. You can fill in the blank there, but if scientists can find a way to upscale the process so that it works for automotive seals, then it could be good news for people in sunny climates some 10 to 15 years later.
All the people in Phoenix are hoping that the time comes sooner rather than later.
Got a tip or question for the author? Contact them directly: caleb@thedrive.com
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Thermo Fisher Scientific Introduces the Oncomine Comprehensive Assay Plus on the Ion Torrent Genexus System to Help Advance the Future of Precision Medicine
Thermo Fisher Scientific Introduces the Oncomine Comprehensive Assay Plus on the Ion Torrent Genexus System to Help Advance the Future of Precision Medicine

Yahoo

time15 minutes ago

  • Yahoo

Thermo Fisher Scientific Introduces the Oncomine Comprehensive Assay Plus on the Ion Torrent Genexus System to Help Advance the Future of Precision Medicine

New assay provides clinical research labs with an all-in-one comprehensive genomic profiling solution that delivers next-day results CARLSBAD, Calif., July 14, 2025--(BUSINESS WIRE)--Today, Thermo Fisher Scientific announced that the Oncomine™ Comprehensive Assay Plus* is now available on the Ion Torrent™ Genexus™ System* helping accelerate precision oncology research. The Oncomine Comprehensive Assay Plus detects a broad range of genomic alterations in 517 genes and will now be able to deliver comprehensive genomic profiling (CGP) results as soon as the next day, enabled by Ion Torrent technology and easy, automated workflows. CGP facilitates the simultaneous analysis of a broad range of biomarkers in one test to maximize insights on the underlying oncogenic drivers in a timely manner. Already available on the Ion GeneStudio™ S5 systems*, the Oncomine Comprehensive Assay Plus detects single-nucleotide variants, insertions and deletions, copy number variations, and fusions. Additionally, the assay detects genomic signatures such as homologous recombination deficiency (HRD), tumor mutational burden (TMB) and microsatellite instability (MSI). With the capabilities of the Genexus System, researchers can now detect a broad range of these important biomarkers, quickly and easily. "We have been waiting for this complete and rapid CGP solution that includes all the relevant biomarkers including TMB, MSI and HRD," said Hector M Alcaraz, MS, Founder of Imagene Health, SA de CV, an early access user of the Oncomine Comprehensive Assay Plus on the Genexus System. "This will make CGP more accessible to our local markets so that we can drive the future of precision medicine forward." The Genexus System is an automated and integrated NGS platform capable of delivering NGS results as soon as the next day. With end-to-end automation that requires less hands-on time, the Genexus System makes genomic profiling accessible to more researchers with varying levels of experience. Now, with the Oncomine Comprehensive Assay Plus available on the Genexus System, research teams can leverage this end-to-end solution to deliver accurate and robust CGP results as soon as the next day. "In recent years, new genomic insights have played an essential role in advancing our understanding of human health and driving novel drug development," said Kathy Davy, president of Clinical Next Generation Sequencing at Thermo Fisher Scientific. "The addition of the Oncomine Comprehensive Assay Plus on the Genexus System brings the benefits of rapid CGP to more labs, empowering researchers to leverage more comprehensive results at a much faster pace and accelerate what could be life-saving research." For more information about the Oncomine Comprehensive Assay Plus on the Genexus System and how this is enabling research labs to accelerate oncology research, please visit *For Research Use Only. Not for use in diagnostic procedures. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit View source version on Contacts Media Contact Information:Jen CarrollPhone: (760) 583 - 8898E-mail: Jessika ParryPhone: 419-266-4016Email: jparry@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Niagen Bioscience Announces the Debut of Tru Niagen® and Niagen IV at Equinox Hotel New York
Niagen Bioscience Announces the Debut of Tru Niagen® and Niagen IV at Equinox Hotel New York

Yahoo

time16 minutes ago

  • Yahoo

Niagen Bioscience Announces the Debut of Tru Niagen® and Niagen IV at Equinox Hotel New York

Both Tru Niagen, featured as the newest in-room offering for hotel guests, and Niagen IV, available at NutriDrip's location at The Spa by Equinox Hotel New York, support cellular energy production and DNA repair for optimal recovery LOS ANGELES, July 14, 2025--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the inaugural hotel debut of Tru Niagen® as an in-room amenity at the Equinox Hotel New York, and Niagen IV, now available at the hotel's spa through NutriDrip. Rob Fried, CEO of Niagen Bioscience, remarked, "Our partnership with Equinox Hotel and NutriDrip underscores our commitment to growing consumer access, driving brand strength, and capturing new market opportunities for our flagship Niagen products." Equinox Hotels, a luxury hospitality brand built on the evolution of Equinox, has been thoroughly conceptualized and brought to life to translate a high-performance lifestyle into a seamless guest experience through cutting-edge and science-backed fitness, recovery, and nutrition services. Hotel guests can now experience the transformative cellular health benefits of Tru Niagen, the number one healthy-aging NAD+ supplement in the United States†, with bottles available as the newest in-room offering. Additionally, the groundbreaking pharmaceutical-grade product, Niagen IV, is available at The Spa by Equinox Hotel New York through NutriDrip. Angela Portella, Director of Spa at Equinox Hotel, commented, "At Equinox Hotels, we provide our community with the highest quality, science-backed products and services. Tru Niagen, recognized as the gold-standard NAD+-boosting supplement, and NutriDrip, the best in the IV therapy business, reflect our mission." Tru Niagen and Niagen IV are powered by Niagen Bioscience's clinically proven flagship ingredient, Niagen® (patented nicotinamide riboside or NR), the most efficient, well-researched, and high-quality NAD+ booster available. NAD+ is a vital coenzyme found in every cell of the human body that supports cellular energy production and DNA repair to support recovery. Asa Kitfield, Managing Partner at Clean Market & NutriDrip, remarked, "We are thrilled to offer Niagen IV at our premium Equinox Hotel New York location. This cutting-edge infusion represents a profound advancement for elevating NAD+ intravenously. It's a game-changer for muscle health and recovery." About Tru Niagen and Niagen IV Tru Niagen is backed by the highest scientific and quality standards, including a Nobel Prize winner, 35+ human clinical studies, 400+ published scientific studies, and has been accepted by the world's most rigorous regulatory bodies. All Tru Niagen products are third-party certified, with Tru Niagen Pro 1,000mg and Tru Niagen Stick Packs NSF Certified for Sport, ensuring their safety, quality, and integrity for elite athletes and fitness enthusiasts alike. Niagen IV represents a significant advancement in intravenous NAD+-boosting therapy. NAD+ IV has gained popularity amongst doctors, fitness experts, celebrities, and athletes because of the substantial benefits, but the experience can be unpleasant. In a head-to-head comparison with NAD+ IV, Niagen IV offered superior tolerability, a 75% shorter infusion time, and resulted in a statistically significant 20% increase in whole blood NAD+ levels three hours post-infusion (MedRxiv). For additional information on the science supporting Niagen, visit Learn more about Equinox Hotel New York at and NutriDrip at About Niagen Bioscience: Niagen Bioscience, Inc. (NASDAQ: NAGE), formerly ChromaDex Corp., is the global leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. As a trusted pioneer of NAD+ discoveries, Niagen Bioscience™ is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. The Niagen Bioscience team, composed of world-renowned scientists, works with independent investigators from esteemed universities and research institutions around the globe to uncover the full potential of NAD+. A vital coenzyme found in every cell of the human body, NAD+ declines with age and exposure to everyday lifestyle stressors. NAD+ depletion is a key contributor to age-related changes in health and vitality. Distinguished by state-of-the-art laboratories, rigorous scientific and quality protocols, and collaborations with leading research institutions worldwide, Niagen Bioscience sets the gold standard for research, quality, and innovation. There's a better way to age. At the heart of its clinically proven product portfolio is Niagen® (patented nicotinamide riboside, or NR), the most efficient, well-researched, high-quality, and legal NAD+ booster available. Niagen powers the Company's consumer supplement, Tru Niagen®, the number one NAD+ boosting oral supplement in the United States† (available at and Niagen Plus™, featuring pharmaceutical-grade intravenous (IV) and injectable Niagen products ( Pharmaceutical-grade Niagen IV and injections are compounded and distributed by U.S. FDA-registered 503B outsourcing facilities and are available exclusively at clinics with a prescription. Niagen Bioscience's robust patent portfolio protects NR and other NAD+ precursors. Niagen Bioscience maintains a website at where copies of press releases, news, and financial information are regularly published. †Based on the top-selling dietary supplement brands by revenue per the largest U.S. e-commerce marketplace (as of 1/1/2024 - 12/31/2024). About Equinox Hotels Equinox Hotels is a rapidly expanding, global luxury hospitality brand and management company built off the evolution of Equinox. With a design-forward perspective and 360-approach to luxury lifestyle, our portfolio spans urban, resort, and destination locations globally set in architecturally stunning spaces built for high-performance living. Only Equinox Hotels can seamlessly integrate a hotel experience with an existing community of engaged, loyal members who activate the Clubs daily. Equinox Branded Residences offer lifestyle, status, and the notion of health associated with the Equinox brand and global membership. Equinox Hotels has a robust global pipeline that is defining a new category of luxury. For more information on Equinox Hotels please visit: About NutriDrip As a leader in functional wellness, NutriDrip provides IV Nutrient Therapy for therapeutic and rejuvenating benefits with a full menu of signature Wellness and Recovery IV Drips. Traditional oral supplementation is hard for your body to absorb and results are slow, while IV Nutrient Therapy provides 100% bioavailability for fast-acting results. NutriDrip's signature IV Drips, which are administered by nurse practitioners and registered nurses, utilize fluids, electrolytes, vitamins and minerals to help you feel & function better. Knowing that we all have different health and nutritional needs, NutriDrip takes a personalized approach to wellness with a best-in-class medical team that will help select and customize the right IV Drip protocol for you. Forward Looking Statements: This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, including statements related to infringement or non-infringement of intellectual property rights. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as "expects," "anticipates," "intends," "estimates," "plans," "potential," "possible," "probable," "believes," "seeks," "may," "will," "should," "could" or the negative of such terms or other similar expressions. Risks that contribute to the uncertain nature of these forward-looking statements include our history of operating losses and need to obtain additional financing; the growth and profitability of our product sales; our ability to maintain sales, marketing and distribution capabilities; changing consumer perceptions of our products; our reliance on a single or limited number of third-party suppliers; and the risks and uncertainties associated with our business and financial condition. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and actual results may differ materially from those suggested by these forward-looking statements. All forward-looking statements are qualified in their entirety by this cautionary statement and Niagen Bioscience undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof. View source version on Contacts Niagen Bioscience Media Contact: Kendall Knysch, Senior Director of Media Relations & Niagen Bioscience Investor Relations Contact: ICR, LLCReed Anderson(646) 277-1260Stephanie Carrington(646) 277-1282niagenir@ Equinox Hotels Media Contact: Caroline McKayCaroline@

Mark Rober's Bold Plan To Reach One Billion Young Minds
Mark Rober's Bold Plan To Reach One Billion Young Minds

Forbes

time16 minutes ago

  • Forbes

Mark Rober's Bold Plan To Reach One Billion Young Minds

Mark Rober When Mark Rober built a glitter bomb for porch pirates he sparked a global movement around science storytelling that is now on track to transform STEM education for the next generation. His latest ambition? To reach one billion brains. 'My North Star is to reach as many brains as possible with the message that science doesn't have to be boring or hard to understand,' says Rober. 'I want to spark a love of science and engineering in the next generation of big problem solvers. That's my why, and my how is CrunchLabs.' What started as a wildly successful YouTube channel, now with 69 million subscribers and over 1 billion monthly views, has become a multi-pronged educational brand that spans subscription boxes, YouTube storytelling, a forthcoming national curriculum and soon, retail toy aisles across America. 'We're growing from YouTube and subscription products to become the leading brand in STEM worldwide to ignite curiosity and resilience in millions more people,' says Rober. At the heart of this operation is CrunchLabs, the company he co-founded with Jim Lee, a former Google executive who serves as President and COO. Jim Lee CrunchLabs launched in June 2022 with a single video: a tour of Rober's secret lab. Within days, they sold out of their first product line, a monthly subscription box called Build Box. Since then, the company has grown rapidly, reaching over 200,000 subscribers across the world. But for Rober and Lee, subscriptions are just the starting point. 'The future holds more in terms of education,' Lee explains. 'Mark actually wanted to become a teacher. He realized that with this platform, we could change science education in a much more meaningful way.' That vision is now crystallizing into Class CrunchLabs, a comprehensive, freely available, next-generation science curriculum for middle schools. Developed by the same team behind Rober's videos and products, it combines high-production-value storytelling with hands-on experiments aligned to national standards. 'We've actually created a pilot episode of a science class,' says Lee. 'We're observing classrooms, gathering feedback, and really trying to make this the best curriculum ever made. Our goal is to make science feel as engaging as a Mark Rober video, and that's never been done before.' CrunchLabs' second major initiative is a multi-channel expansion strategy, combining streaming, retail and licensing deals to diversify revenue while amplifying impact. In May, the company inked a deal with Moose Toys, one of the world's top toy makers, to bring CrunchLabs toys to shelves in 2026. 'A year ago, we had the idea to take over the STEM toy aisle in Target and Walmart,' says Lee. 'Since then I hired a 30-year retail toy veteran, Rachele Harmuth, to be our Head of Commercialization and Product. We paired her with our mechanical engineers and partnered with the world's best toy company for the creator economy: Moose Toys.' Just a month later, CrunchLabs announced the hire of Scott Lewers, a former Discovery Channel executive and Emmy Award-winner, as the company's first Chief Content Officer. 'Scott will lead the creation of original, high-impact science storytelling across screens and into classrooms worldwide,' says Lee. 'This is a huge leap forward in our mission to reach as many brains as possible.' A defining principle of CrunchLabs is that education should never feel like a lecture. Instead of balancing fun and learning, they lead with fun, trusting that curiosity will naturally follow. 'We don't balance it, it's all entertainment,' says Lee. 'The whole goal is to spark that initial interest. You click on a video about a 15-ton Jell-O pool and before you know it, you're learning physics. That's the magic.' Each product takes roughly a year to develop, meticulously crafted by a team of engineers, storytellers and, of course, Rober himself. Every build is tested by kids and adults, certified for safety and paired with a cinematic video that delivers scientific concepts through narrative and surprise. 'We measure success not in dollars or subscribers, but in whether we're meaningfully changing kids' interest in STEM,' says Lee. 'And we survey that. Today, nearly every parent says yes, there's a noticeable, material change in their child's interest because of CrunchLabs.' What sets CrunchLabs apart in an era of venture-backed hypergrowth is its bootstrapped, profitable model. Despite the massive scale of its content the company has avoided outside capital in favor of sustainability. 'We've resisted the VC-backed 'growth at all costs' approach,' says Lee. 'We're building something enduring.' That long-term thinking even shapes their internal culture. Every few months, CrunchLabs hosts a 'No Real Work Day,' where the team builds bikes for kids, shares lunch and then plays with their own inventions from Nerf cannons to foam pits. 'People think we're just playing with squirrels in Mark's backyard,' Lee laughs. 'The reality is, it's a highly skilled team doing serious work to change science education forever.' Mark Rober's mission to reach one billion brains is a real, measurable target driving every decision. And with a unique fusion of creator authenticity, educational impact, and product excellence, CrunchLabs is positioning itself as a new model for science education at scale. In a time when traditional science classrooms face underfunding and outdated materials, Rober and his team are building a compelling, scalable alternative - one that just might inspire the next generation of engineers, inventors and problem solvers. And perhaps most importantly, they're making science feel like magic again. This article is based on an interview with Jim Lee from my podcast, The Business of Creators.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store